CELLphenomics offers patient-derived in vitro assays that recapitulate the original tissue in a robust and high-throughput format.
We test compounds for oncology including immuno-oncology.

5 REASONS WHY YOU SHOULD CONSIDER PD3D® FOR YOUR IN VITRO EXPERIMENTS

CELLphenomics delivers innovative PD3D® models to oncology drug development, accelerating your journey from the laboratory bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives.

1. Recapitulation of the tissue architecture

PD3D® culture models have been shown to reliably recapitulate the architecture of the donor tissue.

2. Preserving the donor tumor's genotype

In the past, 3D organoid models have shown their relevance in the pre-clinical setting. Beside the preservation of tissue architecture, their main benefit over mouse models is the preservation of the genomic background from the donor tissue.

3. VERSATILITY

4. THROUGHPUT

We have developed protocols that allow for semi-automated screening of PD3D® models.

5. CLINICAL & -OMICS DATA

For most of our models basic clinical data of the donor tumor are available. Together with data from exome- and RNA-sequencing our models are the foundation of your research projects. 

CONTACT US

Ask your questions or request an introductory call

REACH OUT

CELLphenomics GmbH

Robert-Rössle-Str. 10
13125 Berlin
Germany

Email

For General Enquiries: hello@cellphenomics.com
For job applications: jobs@cellphenomics.com

Telephone

+49 30 9489 4420

VAT number: DE296393903